Variant report

Variant	esv2752131
Chromosome Location	chr6:92004303-92101703
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:10)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:92039625..92040672-chr6:92243858..92245014,7	MCF-7	breast:
2	chr6:92025048..92027862-chr6:92036199..92038247,2	K562	blood:
3	chr6:92039721..92040294-chr6:93354118..93354772,2	MCF-7	breast:
4	chr6:92024328..92026291-chr6:92028411..92031026,2	MCF-7	breast:
5	chr6:92039620..92040133-chr6:92244085..92244800,2	MCF-7	breast:
6	chr6:92055587..92058216-chr6:92087583..92089845,2	MCF-7	breast:
7	chr6:92055587..92058216-chr6:92087583..92089845,2	MCF-7	breast:
8	chr6:92024328..92026291-chr6:92028411..92031026,2	MCF-7	breast:
9	chr6:30582867..30584827-chr6:92085205..92087278,2	MCF-7	breast:
10	chr6:92025048..92027862-chr6:92036199..92038247,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MAP3K7-1	chr6:92100031-92100262	XLOC_005782

No data

Variant related genes	Relation type
ENSG00000265419	chromatin interactions
ENSG00000222894	chromatin interactions

Extended variants
information (count: 1620 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:1620 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs6923112	chr6:92004303-92004304	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs146868099	chr6:92004319-92004320	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs192527336	chr6:92004321-92004322	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs184383841	chr6:92004326-92004327	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs74551282	chr6:92004378-92004379	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs199657975	chr6:92004426-92004427	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs6903522	chr6:92004439-92004440	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs576551337	chr6:92004464-92004465	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs79689224	chr6:92004474-92004475	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs565406769	chr6:92004489-92004490	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs140246887	chr6:92004504-92004505	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs541222114	chr6:92004514-92004515	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs372703446	chr6:92004527-92004528	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs557676557	chr6:92004552-92004553	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs528946477	chr6:92004580-92004581	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs540613815	chr6:92004643-92004644	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs559161210	chr6:92004676-92004677	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs562123136	chr6:92004718-92004719	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs531241705	chr6:92004788-92004789	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs75084890	chr6:92004800-92004801	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs571421684	chr6:92004816-92004817	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs150285164	chr6:92004861-92004862	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs547232040	chr6:92004899-92004900	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs567506376	chr6:92004907-92004908	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs536739101	chr6:92004918-92004919	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs77898045	chr6:92004934-92004935	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs576627771	chr6:92004965-92004966	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs538630267	chr6:92004987-92004988	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs558916947	chr6:92005081-92005082	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs137987295	chr6:92005091-92005092	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs541751400	chr6:92005095-92005096	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs561143390	chr6:92005109-92005110	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs113871044	chr6:92005122-92005123	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs200866484	chr6:92005161-92005162	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs542299881	chr6:92005173-92005174	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs149056414	chr6:92005178-92005179	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs531455508	chr6:92005233-92005234	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs373997063	chr6:92005298-92005299	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs34837528	chr6:92005316-92005317	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs551042981	chr6:92005345-92005346	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs564905428	chr6:92005367-92005368	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs527579727	chr6:92005368-92005369	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs547712490	chr6:92005425-92005426	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs567444964	chr6:92005437-92005438	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs536482586	chr6:92005512-92005513	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs550024556	chr6:92005551-92005552	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs570118307	chr6:92005639-92005640	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs539135224	chr6:92005660-92005661	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs192586721	chr6:92005775-92005776	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs566113249	chr6:92005865-92005866	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Autism	22495311	CNVD
Gastric cancer	17908304	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Systemic lupus erythematosus	17503323	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
T-cell lymphomas	19863542	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Ependymoma	16718352	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Urothelial carcinoma	18382360	CNVD
Ovarian neoplasms	16753589	CNVD
Hepatocellular carcinoma	16750200	CNVD
Wilms tumour	21544195	CNVD
Follicular lymphoma	17699855	CNVD
Breast cancer	17133270	CNVD
Leukemia	18688285	CNVD
Prostate cancer	19242612	CNVD
Glioma	21046410	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Zellweger syndrome	21572526	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Lung adenocarcinoma	21935476	CNVD
Mental retardation	21045960	CNVD
Obesity	21045960	CNVD
learning difficulties	21045960	CNVD
Prostate cancer	17245344	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Cancer	20164920	CNVD
Burkitt''s lymphoma	20823134	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Chondromyxoid Fibroma	20696777	CNVD
Cancer	21183584	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Breast cancer	21364760	CNVD
Developmental delay	19490664	CNVD
Myelofibrosis	22110671	CNVD
Urothelial cell carcinoma	18451213	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Adrenocortical carcinoma	18281524	CNVD
small cell lung cancer	20016488	CNVD
Neuropathy	19664229	CNVD
Neurodevelopmental disorder	22521361	CNVD
Burkitt''s lymphoma	18698080	CNVD

Chromatin state (count:162 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:92003400-92008800	Weak transcription	Muscle Satellite Cultured Cells	--
2	chr6:92005000-92005200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
3	chr6:92005000-92005200	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
4	chr6:92005400-92008000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
5	chr6:92007800-92008000	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr6:92007800-92008600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
7	chr6:92008000-92008200	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
8	chr6:92008000-92008200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
9	chr6:92008000-92008600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
10	chr6:92008000-92008800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
11	chr6:92008000-92009400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
12	chr6:92008000-92010000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
13	chr6:92008000-92010000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
14	chr6:92008200-92008600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
15	chr6:92008200-92008800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
16	chr6:92008400-92009800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
17	chr6:92008400-92010000	Enhancers	Fetal Stomach	stomach
18	chr6:92008600-92008800	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
19	chr6:92008600-92009000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
20	chr6:92008600-92009200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
21	chr6:92008600-92009400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
22	chr6:92008600-92009400	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
23	chr6:92008600-92009600	Enhancers	Cortex derived primary cultured neurospheres	brain
24	chr6:92008600-92009800	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
25	chr6:92008600-92010000	Enhancers	NH-A	brain
26	chr6:92008800-92009200	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
27	chr6:92008800-92009400	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr6:92008800-92009400	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
29	chr6:92008800-92009800	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
30	chr6:92008800-92010000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
31	chr6:92008800-92010200	Enhancers	Muscle Satellite Cultured Cells	--
32	chr6:92009000-92009200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
33	chr6:92009000-92009200	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
34	chr6:92009000-92009200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
35	chr6:92009000-92009400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr6:92009000-92009400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
37	chr6:92009000-92009800	Enhancers	Ovary	ovary
38	chr6:92009000-92010000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
39	chr6:92009200-92009400	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
40	chr6:92009200-92009800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
41	chr6:92009200-92009800	Enhancers	Aorta	Aorta
42	chr6:92009200-92010000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
43	chr6:92009400-92009600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
44	chr6:92009400-92009600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
45	chr6:92009400-92009600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
46	chr6:92009400-92009600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
47	chr6:92009400-92009800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
48	chr6:92009400-92010000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
49	chr6:92009600-92009800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
50	chr6:92009600-92009800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links